London Area, United Kingdom
Specializing in pharmaceutical and healthcare data strategy, I drive forward-thinking solutions by leveraging real-world insights for optimal analytics outcomes. I advocate that a wealth of data, without a clear strategy, is a missed opportunity. My approach centers on enhancing organizational performance through data-driven decision-making. Utilizing advanced tools such as data science, quantum computing, and generative AI, I'm committed to shaping the 2030 vision for healthcare companies.
As Co-Founder of GroWize, I lead the product vision and strategy: turning complex farm compliance into a simple, farmer-first digital experience. I define what we build and why, prioritise the roadmap, translate EU and Irish requirements into usable workflows, and ensure our platform stays ahead of the 2027 digitised spray recordkeeping shift. 🚜📲🇪🇺 I also drive differentiation, including Ireland’s first database of sprays, pesticides and crops, aligning teams and partners around a clear, scalable product direction.📲🌾
As Head of the Operational Design Center at Merck Healthcare, I am responsible for leading and evolving a multidisciplinary team focused on transforming how we plan and operationalize clinical trials. I oversee two key functions: • Operational Design Support – a team of Operational Design Leads who partner with study teams to deliver country, site, and enrollment strategies. • Operational Design Capabilities – a group led by our Trial Analytics Lead, advancing the use of data science, machine learning (ML), and artificial intelligence (AI) in trial planning. My role is to drive the strategic vision, operational excellence, and cultural shift required to modernize our approach to trial design. This includes embedding data-driven decision-making into planning processes, upskilling the team in AI-enabled analytics, and streamlining collaboration across functions. We deliver impact at three pivotal timepoints in Merck’s Clinical Operations governance model: 1. High-Level Operational Planning 2. Early Feasibility 3. Design Feasibility Through the integration of historical trial data, predictive modeling, and protocol optimization tools, we are evolving from reactive planning to proactive design—reducing trial complexity, increasing site and patient engagement, and enabling more efficient, scalable execution of global studies. This role is central to Merck’s ambition to lead in data-enabled clinical operations, intelligent protocol design, and AI-powered trial planning.
Strategic Visionary in Digital Transformation & Analytics Leadership with Proven Analytics Portfolio Management Expertise With a keen eye for Strategic Vision, I've been at the forefront of advancing analytical capabilities, particularly in site intelligence, operational metrics, and quality indicators. My prowess in Digital Transformation has been instrumental in the on-time delivery and precision of a diverse suite of predictive models, leveraging ML/AI and Generative AI technologies. My role extends beyond mere strategy. I've championed an analytical development portfolio including in-house data & analytics transaction platform serving >1400 users, generative ai and advanced modelling for business intel, ensuring robust analytical methodologies are in place, which has been pivotal for leadership and governance decisions. My expertise in Business Analytics and Product Analytics has been the backbone of this success, coupled with a budget management responsibility of >$5M. Building and nurturing relationships is at the core of my approach. I've continuously influenced key organizational stakeholders, ensuring the seamless adaptation and implementation of analytics and intelligence strategies. My proficiency in Engagement Management and Data Governance has been crucial in maintaining positive vendor partnerships, emphasizing quality delivery and continuous improvement. As a people leader, I've instilled a performance-centric culture, emphasizing Business Planning and actionable metrics. My commitment to Data Strategies and analytical thinking has ensured project and portfolio deliveries are not just timely but also rooted in process improvement. I've coordinated work with an agile mindset, ensuring products are delivered with consistency and precision. My technical acumen extends to Natural Language Processing (NLP), Business Intelligence (BI), data visualization, and cloud platforms including AWS, positioning me at the intersection of strategy and technology.
Innovative Analytics Leader in Site Intelligence with Proven Team-Building & Strategic Development Expertise At the helm of Advanced Analytics, I've spearheaded the technical capabilities pertaining to Site Intelligence, ensuring the delivery of cutting-edge, high-quality results. My leadership extended to the establishment of a robust 20-member team comprising analysts and data scientists. This team was pivotal in championing innovative analytics approaches and methodologies, all aimed at driving efficiencies and aligning with organizational stretch goals. My knack for innovation is evident in the development of novel approaches to site selection & feasibility methodologies. I've been proactive in assessing and reporting the potential impact of these emerging methodologies on overarching business strategies, ensuring alignment and foresight. As a Cross-Functional Team Leader, I've heightened awareness around Site Intelligence and Feasibility initiatives. My collaborative spirit has enabled seamless interactions with a diverse range of stakeholders, both internal and external, ensuring cohesive and impactful project deliveries. Central to my leadership style is fostering a culture that values speed, agility, and accountability. I've been instrumental in cultivating significant internal and external partnerships, consistently adding value and insights to the organization. My approach is insight-driven, always on the lookout to uncover and address crucial unmet needs, ensuring the organization remains ahead of the curve.
Strategic Analytics Expert: Pioneering Next-Gen Site Intelligence with ML & Advanced Statistical Techniques With a deep-rooted expertise in analytics, I've adeptly applied statistical analysis and visualization techniques to elevate site intelligence projects. My collaboration with the Head of Site Feasibility and Selection has been instrumental in championing bold move initiatives and seamlessly transitioning to next-generation analytics. My vision for data-driven opportunities in Site Intelligence has been transformative. I've designed and spearheaded the identification of business prospects leveraging Machine Learning, focusing on study site strategies and Real-World Evidence/Data (RWE/RWD) projects to enhance patient access. In the realm of advanced analytics, I've conceptualized the development of ML techniques for classification and prediction tasks. This involved pioneering new algorithms specifically tailored to optimize country & site placement opportunities, ensuring optimal clinical trial conduct. My collaborative approach has been key in liaising with various business units. Together, we've successfully implemented ML/AI Site Intelligence initiatives. This success is attributed to effective communication, clear implementation blueprints, and well-defined performance metrics, all executed within agreed timelines and to the highest quality standards.
Data-Driven Strategist: Transforming R&D and Business Development with Integrated Analytics & Clinical Intelligence I've been at the forefront of harnessing the power of integrated analytics, designing comprehensive reports using a clinical intelligence tool. This initiative has been pivotal in enlightening R&D teams within Pharma, as well as our internal marketing and sales divisions. My ability to leverage disparate data sources, encompassing Clinical, sales, and investment portfolio reports, has been transformative. By synthesizing this data, I've addressed critical business queries, unveiling process and development gaps. This insight-driven approach has been instrumental in catalyzing business development opportunities. In determining the best analytic strategies, I've meticulously chosen optimal statistical methods. This precision has enabled the identification of the most suitable sites, investigators, and patient cohorts, ensuring our client's project goals are not only met but exceeded. My commitment to innovation is evident in the new insights I've developed. These actionable recommendations have influenced business partners across all echelons, ensuring data-driven decision-making remains at the core of our operations.
Key team member to provide analytical overview genomic alterations, gene expression, mutation and epigenetic changes across human and animal models to identify drug sensitivity to genomic alterations. The role of my project is to examine the presence of recurring chromosomal deletions and their potential as prognostic markers in breast cancer. In parallel to this project I also examined the effect of Chromosomal loss on the cis (Same Chromosome) and trans (Different Chromosome) interactions across the genome.